Schützenberger, Sebastian https://orcid.org/0000-0002-0499-5397
Keller, F. https://orcid.org/0000-0003-0479-2300
Grabner, S. https://orcid.org/0000-0001-7734-8900
Kontic, D. https://orcid.org/0000-0002-8224-2235
Schallmayer, D. https://orcid.org/0000-0002-3852-7997
Komjati, M. https://orcid.org/0000-0003-1761-6728
Fialka, C. https://orcid.org/0000-0001-9782-7888
Article History
Received: 31 January 2022
Accepted: 6 April 2022
First Online: 19 April 2022
Declarations
:
: Ethical approval was given by the ethics committee of the AUVA, Austria (ID 19/2018). All patients gave their written informed consent to participate in this clinical trial.
: S. Schützenberger has received personal fees (lecture fees) from Arthrex. The other authors declare that they have no competing interests.